Get started
OOO

JAYAMAS MEDICA INDUSTRI TBK

No trades
See on Supercharts
Overview
Financials Ideas Discussions Technicals Forecast Seasonals

OMED chart


Full chart

Key stats


Market capitalization
‪4.87 T‬ IDR
Dividend yield (indicated)
1.60%
Price to earnings Ratio (TTM)
17
Basic EPS (TTM)
11 IDR
Net income (FY)
‪259.36 B‬ IDR
Revenue (FY)
‪1.74 T‬ IDR
Shares float
‪4.04 B‬
Beta (1Y)
−0.06

Employees


Employees (FY)
‪1.11 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪101.62 K‬ IDR
Net income / Employee (1Y)
‪15.17 K‬ IDR

About JAYAMAS MEDICA INDUSTRI TBK


Sector
Health Technology
Industry
Medical Specialties
CEO
Herlien Sri Ariani
Website
onemed.co.id
Headquarters
Sidoarjo
Founded
2000
ISIN
ID1000176209
FIGI
BBG019Y3PH55
PT Jayamas Medica Industri engages in the manufacture, wholesale, and retail trade of medical equipment. It operates through the following segments: Medical Disposable and Consumable, Antiseptic and Dialysis Fluid, Diagnostic and Equipment, Walking Aids and Rehab, Biotech and Lab, and Hospital Furniture. The Medical Disposable and Consumable segment includes medical gloves, syringes, wound care, masks, and others. The Antiseptic and Dialysis Fluid segment focuses on disinfectants, dialysis fluids, antiseptic swabs and wipes, and gels. The Diagnostic and Equipment segment involves digital and manual blood pressure monitors, infusion and syringe pumps, thermometers, and others. The Walking Aids and Rehab segment refers to wheelchairs and others. The Biotech and Lab segment covers disposable laboratories, pregnancy tests, blood collection tubes, and others. The Hospital Furniture segment consists of patient beds, cupboards and trolleys, cabinets, and others. The company was founded by Jemmy Hartanto on December 15, 2000 and is headquartered in Sidoarjo, Indonesia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of OMED is 178 IDR — it has decreased by −1.11% in the past 24 hours. Watch JAYAMAS MEDICA INDUSTRI TBK stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on IDX exchange JAYAMAS MEDICA INDUSTRI TBK stocks are traded under the ticker OMED.
OMED stock has risen by 0.56% compared to the previous week, the month change is a 1.71% rise, over the last year JAYAMAS MEDICA INDUSTRI TBK has showed a −13.59% decrease.
We've gathered analysts' opinions on JAYAMAS MEDICA INDUSTRI TBK future price: according to them, OMED price has a max estimate of 192.00 IDR and a min estimate of 192.00 IDR. Watch OMED chart and read a more detailed JAYAMAS MEDICA INDUSTRI TBK stock forecast: see what analysts think of JAYAMAS MEDICA INDUSTRI TBK and suggest that you do with its stocks.
OMED reached its all-time high on Nov 18, 2022 with the price of 280 IDR, and its all-time low was 149 IDR and was reached on Aug 29, 2023. View more price dynamics on OMED chart.
See other stocks reaching their highest and lowest prices.
OMED stock is 8.43% volatile and has beta coefficient of −0.06. Track JAYAMAS MEDICA INDUSTRI TBK stock price on the chart and check out the list of the most volatile stocks — is JAYAMAS MEDICA INDUSTRI TBK there?
Yes, you can track JAYAMAS MEDICA INDUSTRI TBK financials in yearly and quarterly reports right on TradingView.
OMED net income for the last quarter is ‪66.98 B‬ IDR, while the quarter before that showed ‪80.49 B‬ IDR of net income which accounts for −16.79% change. Track more JAYAMAS MEDICA INDUSTRI TBK financial stats to get the full picture.
Yes, OMED dividends are paid annually. The last dividend per share was 2.88 IDR. As of today, Dividend Yield (TTM)% is 1.60%. Tracking JAYAMAS MEDICA INDUSTRI TBK dividends might help you take more informed decisions.
JAYAMAS MEDICA INDUSTRI TBK dividend yield was 1.35% in 2023, and payout ratio reached 30.05%. The year before the numbers were 1.50% and 30.01% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has ‪1.11 K‬ employees. See our rating of the largest employees — is JAYAMAS MEDICA INDUSTRI TBK on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JAYAMAS MEDICA INDUSTRI TBK EBITDA is ‪393.06 B‬ IDR, and current EBITDA margin is 20.63%. See more stats in JAYAMAS MEDICA INDUSTRI TBK financial statements.
Like other stocks, OMED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JAYAMAS MEDICA INDUSTRI TBK stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JAYAMAS MEDICA INDUSTRI TBK technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JAYAMAS MEDICA INDUSTRI TBK stock shows the buy signal. See more of JAYAMAS MEDICA INDUSTRI TBK technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.